Conference
879P Activity of cabozantinib (cabo) after PD-1/PD-L1 immune checkpoint blockade (ICB) in metastatic clear cell renal cell carcinoma (mccRCC)
Authors
McGregor BA; Lalani A-K; Xie W; Steinharter JA; Martini DJ; Nuzzo PV; Chanza NM; Harshman LC; Bilen MA; Choueiri TK
Volume
29
Publisher
Elsevier
Publication Date
October 2018
DOI
10.1093/annonc/mdy283.088
Conference proceedings
Annals of Oncology
ISSN
0923-7534